Award
California Department of Veterans Affairs 5IK2CX002606-02
Examining ketamine effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease
Recipient
Veterans Affairs (VA)
Awarded
July 08, 2026
Identifier
5IK2CX002606-02
A clinical trial funded by the Veterans Affairs to study ketamine's impact on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease.
Description
This project involves a clinical trial to examine the effects of ketamine on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease. It is funded by the VA and aims to develop new pharmacologic treatments for neuropsychiatric disorders.